Monthly Dealtracker: October 2026
October’s dealmaking reflected contrasting trends across M&A and private equity, with large-ticket transactions driving M&A values and smaller investments gaining traction in private equity.
For more updates follow Grant Thornton Bharat on WhatsApp

India’s deal-making activity maintained robust momentum in February 2026, supported by strong private equity and venture capital participation alongside resilient M&A transactions. The February 2026 edition of our Dealtracker publication provides a detailed view of sector-specific capital deployment, highlighting high-value energy investments, technology-led innovation funding, and broad-based activity. It discusses the evolving dynamics of deal volumes and values, illustrating both large-scale transactions and smaller ticket deals that reflect strategic growth and investor confidence. This publication captures the breadth and depth of India’s investment landscape.
Energy & natural resources sector emerged as the strongest performing sectors in this month, with deal volumes rising sharply by 217%, while aggregate deal values increased by 3x compared to the previous month.
Retail & Consumer led overall deal activity, recording 63 transactions and contributing 23% of total volumes. However, despite the strong volume growth, aggregate deal value declined by 38%, resulting in a contraction in average deal size from USD 19 million to USD 7 million month-on-month, indicating a shift towards small-ticket transactions.
This sector emerged as the second-highest contributor to value in February, with Tech start-ups dominating, accounting for 81% of total sector value and 56% of volumes, largely concentrated on AI-focused platforms.
Pharma, Healthcare & Biotech experienced strong acceleration, with deal volumes rising 94% and total values increasing 4.1x over the previous month. Three transactions exceeding USD 100 million supported higher capital deployment.
The Real estate sector exhibited a divergent trend, with deal volumes increasing 67% month-on-month, while values declined 15%. Despite the value moderation, the sector recorded two high-value transactions totaling USD 186 million, including an insolvency-led acquisition by the Amtek Group of the Supertech ORB project.
Banking & Financial Services retained its position as the third-largest contributor by value, recording 21 deals totaling USD 728 million, reflecting steady capital inflows.


October’s dealmaking reflected contrasting trends across M&A and private equity, with large-ticket transactions driving M&A values and smaller investments gaining traction in private equity.
India’s pharma and healthcare sector remained active in Q3 2026 as organisations advanced consolidation, regional expansion and capability-building agendas.
The consumer and retail sector saw investors become more selective in Q3 2026, with capital favouring differentiated brands, category leaders and scalable business models. Public markets emerged as an important funding avenue, while premiumisation remained a key investment theme across consumer segments. The Q3 2026 edition of the Consumer and Retail Dealtracker analyses deal activity across M&A, private equity, venture capital and public markets, and highlights the trends influencing investment decisions across the sector.